From Liston Street Pulse:
Shares of Ventrus Biosciences Inc. (VTUS), a specialty pharmaceutical company engaged in the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, have skyrocketed in trading today. The stock is soaring after the company announced positive results from clinical dermal safety and pharmacokinetic studies of Diltiazem. At last check, […]
The post Ventrus Biosciences Shares Skyrocket appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015